EOCN (Eocene) 5-Year Yield-on-Cost %: 0.00 (As of Sep. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EOCN Eocene Ltd EOCN
29 GF Score
Price $4.09
! 2 Warning Signs
View Full Analysis

What is Eocene 5-Year Yield-on-Cost %?

Eocene EOCN +21.05% 29 5-Year Yield-on-Cost % is 0.00 as of Sep. 11, 2026. GuruFocus rates EOCN with a GF Score™ of 29/100. The stock has 2 warning signs investors should review. Among 147 Biotechnology companies, Eocene ranks worse than 680271.43% on this metric.

Eocene's yield on cost for the quarter that ended in Jun. 2026 was 0.00.


The historical rank and industry rank for Eocene's 5-Year Yield-on-Cost % or its related term are showing as below:



EOCN's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.63
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Eocene  (NAS:EOCN) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Eocene 5-Year Yield-on-Cost % Related Terms

EOCN vs ELAB, SILO, APVO: 5-Year Yield-on-Cost % Comparison

For the Biotechnology subindustry, Eocene's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eocene 5-Year Yield-on-Cost % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eocene's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Eocene's 5-Year Yield-on-Cost % falls into.


EOCN
29GF Score
Eocene Ltd EOCN
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eocene 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Eocene is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Eocene (EOCN) has a 5-Year Yield-on-Cost % of 0.00 as of Sep. 11, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Eocene and its competitors. According to the industry distribution chart, Eocene ranks #999999 out of 147 companies in the Biotechnology industry.
Is Eocene's 5-Year Yield-on-Cost % too high?
Eocene's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Eocene ranks #999999 out of 147 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Eocene has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Eocene's 5-Year Yield-on-Cost % compare to ELAB and SILO?
According to the Biotechnology industry distribution chart, Eocene ranks #999999 out of 147 companies for 5-Year Yield-on-Cost %. This places Eocene in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.63, based on 147 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Eocene and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eocene's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eocene stock overvalued right now?
Eocene (EOCN) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Eocene's overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Eocene (EOCN), the current 5-Year Yield-on-Cost % is 0.00 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eocene Business Description

Address c/o Meitar Law Offices, 16 Abba Hillel Road, Ramat Gan, ISR, 5250608
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
29GF Score

Get the complete analysis for EOCN

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.09
Price